IT1239743B - New Lactobacillus casei strain - Google Patents
New Lactobacillus casei strainInfo
- Publication number
- IT1239743B IT1239743B IT47536A IT4753690A IT1239743B IT 1239743 B IT1239743 B IT 1239743B IT 47536 A IT47536 A IT 47536A IT 4753690 A IT4753690 A IT 4753690A IT 1239743 B IT1239743 B IT 1239743B
- Authority
- IT
- Italy
- Prior art keywords
- lactobacillus casei
- strain
- casei strain
- new lactobacillus
- casei
- Prior art date
Links
- 244000199866 Lactobacillus casei Species 0.000 title abstract 2
- 235000013958 Lactobacillus casei Nutrition 0.000 title abstract 2
- 229940017800 lactobacillus casei Drugs 0.000 title abstract 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 abstract 2
- 229920001817 Agar Polymers 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000001888 Peptone Substances 0.000 abstract 1
- 108010080698 Peptones Proteins 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 abstract 1
- 239000008272 agar Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 abstract 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 abstract 1
- 235000019797 dipotassium phosphate Nutrition 0.000 abstract 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 229940040511 liver extract Drugs 0.000 abstract 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 abstract 1
- 235000019341 magnesium sulphate Nutrition 0.000 abstract 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 abstract 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 abstract 1
- 235000019319 peptone Nutrition 0.000 abstract 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 abstract 1
- 229920000053 polysorbate 80 Polymers 0.000 abstract 1
- 229940075582 sorbic acid Drugs 0.000 abstract 1
- 235000010199 sorbic acid Nutrition 0.000 abstract 1
- 239000004334 sorbic acid Substances 0.000 abstract 1
- 239000012137 tryptone Substances 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Lactobacillus casei ssp. casei strain 37 (USSR accession no. VKPM V-4914) is claimed for the prodn. of a bacterial biological prepn.. Strain 37 was isolated from healthy human faeces using a selection medium contg. 0.05 g/l MnSO4, 0.2 g/l MgSO4, 2 g/l K2HPO4, 5 g/l NaOAc, 2 g/l NH4 citrate, 2 g/l glucose, 10 g/l peptone, 5 g/l tryptone, 1 g/l Tween 80, 0.2 g/l cystine, 50 g/l yeast autolysate, 100 g/l liver extract, 0.4 g/l sorbic acid and 25 g/l agar.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT47536A IT1239743B (en) | 1990-01-16 | 1990-01-16 | New Lactobacillus casei strain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT47536A IT1239743B (en) | 1990-01-16 | 1990-01-16 | New Lactobacillus casei strain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IT9047536A0 IT9047536A0 (en) | 1990-01-16 |
| IT9047536A1 IT9047536A1 (en) | 1991-07-17 |
| IT1239743B true IT1239743B (en) | 1993-11-15 |
Family
ID=11260958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT47536A IT1239743B (en) | 1990-01-16 | 1990-01-16 | New Lactobacillus casei strain |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1239743B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996026732A1 (en) * | 1995-02-28 | 1996-09-06 | Newpharma S.R.L. | Compositions of lactic acid bacteria and saccharomyces lysates and the therapeutical use thereof |
-
1990
- 1990-01-16 IT IT47536A patent/IT1239743B/en active IP Right Grant
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996026732A1 (en) * | 1995-02-28 | 1996-09-06 | Newpharma S.R.L. | Compositions of lactic acid bacteria and saccharomyces lysates and the therapeutical use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| IT9047536A1 (en) | 1991-07-17 |
| IT9047536A0 (en) | 1990-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0576780T3 (en) | A novel microorganism strain, bacterial compositions comprising the strain and use of the strain and preparations for | |
| DK0554418T3 (en) | Intestinal colonizing lactobacilli | |
| AU2230083A (en) | Fermented beverage | |
| NZ217702A (en) | Lactobacillus casei compositions and antifungal treatment | |
| ES8605032A1 (en) | Variety of Bacillus thuringiensis effective against Coleoptera and an insecticidally active preparation obtainable therefrom, or a toxine, and their use to combate Coleoptera. | |
| CA2111901A1 (en) | Slider Pull Tab | |
| AU2834995A (en) | Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas | |
| FR12C0065I1 (en) | ||
| AU7368091A (en) | Secretion of hirudin derivatives | |
| MX9605670A (en) | Serviceable clip core coupling. | |
| IT1239743B (en) | New Lactobacillus casei strain | |
| ES8305825A1 (en) | Process for the preparation of D-lactic acid using lactobacillus bulgaricus DSM 2129. | |
| AU5470194A (en) | Hirudin mutant, production thereof, anticoagulant, secretory vector, and production of product from said microorganism | |
| ATE128187T1 (en) | PRODUCTION OF AMINO ACIDS BY METHYLOTROPHIC BACILLAS. | |
| EP0528955A4 (en) | Protease deficient bacterial hosts | |
| TH37592A (en) | Production of L (+) - lactate | |
| CA2012835A1 (en) | DNA Probe for Lactobacillus Helveticus | |
| IT1193665B (en) | Proteins corresponding to diphtheria toxin for vaccine prodn. | |
| TW353025B (en) | Omnidirectional suction magnetic ball | |
| IT1167672B (en) | Proteins corresponding to diphtheria toxin for vaccine prodn. | |
| IT1248745B (en) | System for fabricating permanent magnets generating magnetic fields and corresponding elementary or composite permanent magnets | |
| MY131751A (en) | Lactobacillus rhamnosus strain and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted |